Assembly Biosciences (ASMB)Ra Capital Management, L.P. opened a new position $26.1M
Ra Capital Management, L.P. opened a new position in Assembly Biosciences, per its Q3 2025 13F.
- 1.02M
- Shares reported
- 0.32%
- Disclosed portfolio weight
- $26.1M
- Reported value
- Holdings as of
- Sep 30, 2025
- Filed
- Nov 14, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Assembly Biosciences
For Assembly Biosciences, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ASMB page.
How this filing works
Other disclosures at Assembly Biosciences
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRFeb 17, 2026
- SEC Form 13F-HRFeb 13, 2026
- SEC Form 13F-HRNov 14, 2025
- SEC Form 4Apr 15, 2025
- SEC Form 4Apr 1, 2025
Everything OQRO holds on this company is on its ASMB page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data